Back
Blackbaud, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Buy
63
BLKB
Blackbaud, Inc.
Last Price:
$62.38
Seasonality Move:
-1.02%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$68.84
Seasonality Move:
40.49%
Buy
63
Blackbaud, Inc. (BLKB)
is a Buy
Is Blackbaud, Inc. a Buy, Sell or Hold?
-
The current Blackbaud, Inc. [BLKB] share price is $61.36. The Score for BLKB is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
BLKB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.83. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BLKB Stock Price Chart
What is Blackbaud, Inc.'s stock price today?
-
The Blackbaud, Inc. share price today is $61.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLKB is experiencing slight selling pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $68.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
BLKB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 53.72 | Buy |
| Chaikin Money Flow: | -73528 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.58 - 61.28) | Buy |
| Bollinger Bands (100): | (60.16 - 67.06) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.39 | Buy |
| Relative Strength Index (14 RSI): | 76.07 | Buy |
| Chaikin Money Flow: | 2789125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.57 - 58.79) | Buy |
| Bollinger Bands (100): | (20.11 - 45.67) | Buy |
BLKB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.61 | Buy |
| 20-day SMA: | 58.93 | Buy |
| 50-day SMA: | 61.48 | Sell |
| 200-day SMA: | 63.43 | Sell |
| 8-day EMA: | 60.79 | Buy |
| 20-day EMA: | 60.02 | Buy |
| 50-day EMA: | 61.22 | Buy |
| 200-day EMA: | 65.13 | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.94 | Buy |
| 20-day SMA: | 50.39 | Buy |
| 50-day SMA: | 42.93 | Buy |
| 200-day SMA: | 24.04 | Buy |
| 8-day EMA: | 62.02 | Buy |
| 20-day EMA: | 53.73 | Buy |
| 50-day EMA: | 44.48 | Buy |
| 200-day EMA: | 29.61 | Buy |
Blackbaud, Inc. Earnings Growth & BLKB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.52 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
Blackbaud, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||